Ipca Laboratories share price falls 2.01%; among top losers on Nifty Midcap 150

Ipca Laboratories shares declined by 2.01% to Rs 1,349 in Wednesday's session and the stock is among the top losers on Nifty Midcap 150. At 11:24 am, the stock traded lower compared to its previous close.

Financial Overview

The following tables provide a consolidated overview of Ipca Laboratories' financial performance, including quarterly and annual data for revenue, net profit, and key financial ratios.

Consolidated Quarterly Results

The revenue for the quarter ending June 2025 was Rs 2,308.85 Crore, up from Rs 2,092.63 Crore in June 2024. The net profit for the quarter ending June 2025 was Rs 234.42 Crore, compared to Rs 198.98 Crore in the same quarter of the previous year.

Consolidated Annual Results

The annual revenue for 2025 was Rs 8,939.59 Crore, up from Rs 7,705.04 Crore in 2024. The net profit for 2025 was Rs 787.53 Crore, compared to Rs 529.21 Crore in the previous year.

Consolidated Yearly Income Statement

The sales increased from Rs 7,705 Crore in March 2024 to Rs 8,939 Crore in March 2025. Net profit also increased from Rs 529 Crore in March 2024 to Rs 787 Crore in March 2025.

Consolidated Quarterly Income Statement

The sales increased from Rs 2,092 Crore in June 2024 to Rs 2,308 Crore in June 2025. Net profit also increased from Rs 198 Crore in June 2024 to Rs 234 Crore in June 2025.

Cash Flow

Balance SheetFinancial RatiosCorporate Actions

Ipca Laboratories has announced several corporate actions, including dividend payouts and a stock split.

Dividends:

• Final Dividend of Rs.2.00 per share (200%) was announced on May 29, 2025, with an effective date of August 05, 2025.
• Interim Dividend of Rs.2.00 per share (200%) was announced on October 24, 2024, with an effective date of November 25, 2024.

Bonus History:

• A bonus issue with a ratio of 1:1 was announced on October 27, 2004, with an ex-bonus date of January 28, 2005.

Stock Splits:

• The company executed a stock split, with the old face value of Rs 2 being split to a new face value of Rs 1. The ex-split date was January 10, 2022 and record date was January 11, 2022.
• Another stock split was executed earlier, with the old face value of Rs 10 being split to a new face value of Rs 2. The ex-split date was March 22, 2010 and record date was March 23, 2010.

Ipca Laboratories had its Annual General Meeting on August 11, 2025, with the scrutinizer's report submitted to the exchange on August 12, 2025. An audio link for the conference call held on August 12, 2025, is also available.

The stock has seen a decline today, with a Moneycontrol analysis on August 7, 2025, indicating a very bearish sentiment.

With the stock's last traded price at Rs 1,349, Ipca Laboratories is currently trading lower in today's session.